首页> 外文期刊>The international journal of artificial organs >A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF.
【24h】

A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF.

机译:一项随机比较交叉研究,评估与CVVH和CVVHDF相关的不同预稀释量对电路寿命的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To determine if circuit life is influenced by a higher pre-dilution volume used in CVVH when compared with a lower pre-dilution volume approach in CVVHDF. DESIGN: A comparative crossover study. Cases were randomized to receive either CVVH or CVVHDF followed by the alternative treatment. SUBJECTS: All patients >or= 18 yrs of age who required CRRT while in ICU were eligible to participate, but excluded if coagulopathic, thrombocytopenic or unable to receive heparin. Based on an intention-to-treat, 45 patients were randomized to receive either CVVH or CVVHDF followed by the alternative treatment. SETTING: A 24-bed, tertiary, medical and surgical adult intensive care unit (ICU). INTERVENTION: Blood flow rate, vascular access device and insertion site, hemofilter, anticoagulation and machine hardware were standardized. An ultrafiltrate dose of 35 ml/ kg/h delivered pre-filter was used for CVVH. A fixed pre-dilution volume of 600 mls/h with a dialysate dose of 1 L was used for CVVHDF. Results: Thirty-one patients received CVVH or CVVHDF out of 45 participants followed by the alternative technique. There was a significant increase in circuit life in favor of CVVHDF (median=16 h 5 min, range=40 h 23 min) compared with CVVH (median=6 h 35 min, range=30 h 45 min). A Mann-Whitney U test was performed to compare circuit life between the two different CRRT modes (Z=-3.478, p<0.001). Measurements of circuit life on the 93 circuits which survived to clotting (50 CVVH and 43 CVVHDF) were log transformed prior to under taking a standard multiple regression analysis. None of the independent variables - activated prothrombin time (aPTT), platelet count, heparin dose, patient hematocrit or urea - had a coefficient partial correlation >0.09 (coefficient of the determination=0.117) or a linear relationship which could be associated with circuit life (p=0.228). CONCLUSION: Pre-diluted CVVHDF appeared to have a longer circuit life when compared to high volume pre-diluted CVVH. The choice of CRRT mode may be an important independent determinant of circuit life.
机译:目的:确定与CVVHDF中较低的预稀释体积方法相比,CVVH中使用的较高的预稀释体积是否会影响电路寿命。设计:一项比较交叉研究。病例被随机分配接受CVVH或CVVHDF,然后接受替代治疗。受试者:所有在ICU期间需要CRRT的年龄大于或等于18岁的患者都有资格参加,但如果是凝血性,血小板减少性或无法接受肝素的患者则被排除。根据意向性治疗,将45例患者随机分为CVVH或CVVHDF,然后接受替代治疗。地点:24张病床,三级,医疗和外科成人重症监护室(ICU)。干预:对血流速度,血管通路装置和插入部位,滤血器,抗凝和机器硬件进行了标准化。 CVVH使用35 ml / kg / h的超滤剂量预过滤器。 CVVHDF使用固定的600 mls / h的预稀释体积和1 L的透析液剂量。结果:45名参与者中有31名接受了CVVH或CVVHDF的患者,随后采用了替代技术。与CVVH(中位数= 6 h 35 min,范围= 30 h 45 min)相比,使用CVVHDF的电路寿命显着增加(中位数= 16 h 5 min,范围= 40 h 23 min)。进行了Mann-Whitney U测试以比较两种不同CRRT模式之间的电路寿命(Z = -3.478,p <0.001)。在进行标准多元回归分析之前,对93个存活至凝结的电路(50 CVVH和43 CVVHDF)的电路寿命进行对数转换。所有独立变量-激活凝血酶原时间(aPTT),血小板计数,肝素剂量,患者血细胞比容或尿素-均无系数偏相关性> 0.09(测定系数= 0.117)或与电路寿命相关的线性关系(p = 0.228)。结论:与大容量的预稀释CVVH相比,预稀释的CVVHDF似乎具有更长的电路寿命。 CRRT模式的选择可能是电路寿命的重要独立决定因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号